Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system.

@article{Gupta2008TenofovirassociatedFS,
  title={Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system.},
  author={Samir K Gupta},
  journal={AIDS patient care and STDs},
  year={2008},
  volume={22 2},
  pages={99-103}
}
Tenofovir disoproxil fumarate (TDF) is a commonly used HIV antiretroviral. A relatively uncommon adverse effect of this drug is Fanconi syndrome. What is known about this toxicity, especially in regards to concomitant medication use and outcomes, is limited to isolated case reports and small case series. Therefore, a retrospective review of the FDA Adverse Event Reporting System from 2001 through 2006 was conducted to examine demographics, concomitant medication use, outcomes, and temporal… CONTINUE READING